Page last updated: 2024-11-02

oxidopamine and Neoplasm Metastasis

oxidopamine has been researched along with Neoplasm Metastasis in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ieguchi, K1
Funakoshi, M1
Mishima, T1
Takizawa, K1
Omori, T1
Nakamura, F1
Watanabe, M1
Tsuji, M1
Kiuchi, Y1
Kobayashi, S1
Tsunoda, T1
Maru, Y1
Wada, S1

Other Studies

1 other study available for oxidopamine and Neoplasm Metastasis

ArticleYear
The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments.
    International journal of molecular sciences, 2022, Sep-13, Volume: 23, Issue:18

    Topics: Animals; Lung; Lung Neoplasms; Mice; Neoplasm Metastasis; Oxidopamine; Semaphorin-3A; Sympathetic Ne

2022